Bruce Jackson
Stock Analyst at Benchmark
(0.87)
# 3,891
Out of 5,182 analysts
116
Total ratings
31.48%
Success rate
-18.18%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $14 → $10 | $6.07 | +64.74% | 3 | Mar 27, 2026 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $91.13 | +59.11% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $1.08 | +154.63% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $0.70 | +1,900.00% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $45 → $30 | $6.86 | +337.32% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.91 | +458.38% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.52 | +812.70% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $161.26 | -50.39% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $8.29 | - | 8 | Jan 16, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.14 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $7.29 | +311.52% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.32 | +288.80% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $0.81 | +270.42% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.95 | +425.93% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $1.82 | +3,196.70% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $340 | $0.90 | +37,661.00% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.81 | +2,880.81% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $150 | $4.86 | +2,986.42% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.85 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $25.67 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.05 | +38,924.39% | 1 | Aug 8, 2022 |
CapsoVision
Mar 27, 2026
Maintains: Speculative Buy
Price Target: $14 → $10
Current: $6.07
Upside: +64.74%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $91.13
Upside: +59.11%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $1.08
Upside: +154.63%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $0.70
Upside: +1,900.00%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $45 → $30
Current: $6.86
Upside: +337.32%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.91
Upside: +458.38%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.52
Upside: +812.70%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $161.26
Upside: -50.39%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.29
Upside: -
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.14
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $7.29
Upside: +311.52%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.32
Upside: +288.80%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $0.81
Upside: +270.42%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.95
Upside: +425.93%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $1.82
Upside: +3,196.70%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $340
Current: $0.90
Upside: +37,661.00%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.81
Upside: +2,880.81%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $150
Current: $4.86
Upside: +2,986.42%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.85
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $25.67
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.05
Upside: +38,924.39%